drugset / Trial / NCT01084720

Efficacy, Local Tolerance and Patient Acceptability of a Moisturizing Emollient in Patients With Uremic Xerosis

NCT01084720 ↗

Phase 3 Completed 100 enrolled Orfagen
RandomizedSingle-groupDouble-blindTreatment

Summary

* To evaluate the palliative effects of a moisturising emollient, in patients with uremic xerosis of moderate, severe or very severe intensity, associated or not to uremic pruritus. * To assess the local tolerance of the test product and its vehicle, and to evaluate the overall agreement (efficacy, tolerance easiness of use) of the patients for the test product.

Timeline

Start
2002-12
Primary completion
—
Completion
2003-12

Drugs

EvaluationDrugModalityDoseRoute
Subject V0034 CR Unknown — —

Indications

No indication recorded.